Clinical Features and Outcomes of CBP Versus Non-CBP in Septic Children
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age28-18
SponsorChildren's Hospital of Fudan University
About this trial
The effect of continuous blood purification (CBP) in children is unclear. Also, the timing of early application is still being explored. In this study, we need to explore the efficacy and the timing of application of CBP in children with sepsis or septic shock.
Eligibility criteria
Qualifiers
Age of 29d to 18 years old;
Children diagnosed with sepsis requiring blood purification.
Disqualifiers
with a history of a duration of PICU stay <24 h
active bleeding, including cerebral hemorrhage
Trial design
Treatments tested in this trial
- CBP
Treatment groups
90 Participants
are divided into 2 treatment groupsSponsors and collaborators
Children's Hospital of Fudan University
Lead sponsor
Shanghai Children's Hospital
Collaborator
Shanghai Children's Medical Center
Collaborator
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Collaborator
Source ClinicalTrials.gov